pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine clinical programs — 59 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 442
- Patents
- 706
Disc Medicine projects
59 ClinicalTrials.gov programs sponsored by Disc Medicine.
Disc Medicine has 59 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Placebo cannabis oil. Components: cannabis gr... for Refractory Epilepsy
Disc Medicine
Refractory Epilepsy
1 trial -
REINFORCE
Disc Medicine
Metastatic hormone-sensitive prostate cancer
1 trial -
RT2019-13
Disc Medicine
Patients with biochemical recurrence after primary treatment of prostate cancer presenting with =<4 metastases
1 trial -
Safe Stop
Disc Medicine
Melanoma
1 trial -
Safe Stop IPI-NIVO
Disc Medicine
Melanoma
1 trial -
Suprefact Depot 9 for low-volume metastatic castration-sensitive prostate cancer
Disc Medicine
low-volume metastatic castration-sensitive prostate cancer
1 trial -
VERDYE 5 mg/ml poeder voor oplossing voor injectie
Disc Medicine
Histologically confirmed solid malignancy (e.g., head and neck, gastrointestinal, hepatobiliary, breast, genitourinary, sarcoma)
1 trial -
[18F]-AlF-FAPI-74
Disc Medicine
Advanced gastric cancer
1 trial -
[18F]-AlF-FAPI-74
Disc Medicine
Carcinoma of Unknown Primary
1 trial -
[18F]-AlF-FAPI-74 for Cholangiocarcinoma
Disc Medicine
Cholangiocarcinoma
1 trial -
[68Ga]Ga-PentixaFor
Disc Medicine
Primary aldosteronism
1 trial
Frequently asked questions
How many clinical projects does Disc Medicine have?
59 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.